Wilson Alexander Blair
Company insiders · CLO, CSO and Corp Secretary · AEON Biopharma, Inc.
- Reported transaction lines
- 1
- Buy lines
- 1
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Wilson Alexander Blair CLO, CSO and Corp Secretary · AEON Biopharma, Inc. | AEON AEON Biopharma, Inc. | BuyFiling detailsSEC transaction code P Class A Common Stock · Direct ownership · Reported balance after transaction: 2318711 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1235 to $0.1300 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | 2026-11-20 | 2026-11-20 | ≈ $17,478.93 135,706 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.